Traditional treatment for Lyme Disease involves antibiotics, either oral, injections, or IV.  Co-infections frequently require a different treatment plan than antibiotic therapy as they are not always effective for Lyme Disease. The bacteria associated with Lyme Disease are very sensitive to oxygen and are debilitated in a highly oxygenated environment. Research shows a significant improvement when HBOT is used to treat Lyme Disease, even with patients who have not been successful with antibiotic therapy. HBOT decreases inflammation, oxygenates the entire body, stimulates the growth of new healthy blood vessels, and releases stem cells, up to 800% more after twenty sessions. Research shows that the efficacy of antibiotics in the case of Lyme Disease is increased as new blood vessel growth allows the medication to penetrate deeper into tissues.

A Quantitative EEG shows us electrical activity of the brain.  We will be able to see if inflammation is present, if there are any areas of hyper- or hypoactivity, and any areas of disconnect. Patients with Lyme Disease may experience Post Treatment Lyme Disease Syndrome (PTLDS) and may have pain, neurocognitive or fatigue symptoms, headaches, brain fog, and sleep disorders. PTLDS seems to occur more frequently after Lyme that has caused neurological involvement.  Research suggests that the brain becomes more sensitive to pain signals and does not reset after the infection, causing the increased sensitivity to continue. Using the information from the QEEG, we can focus on the area(s) of the brain most affected and bring those areas back into balance using Neurofeedback Therapy.